Scenarios that move PTCT

PTC Therapeutics, Inc. - Common Stock

Scenarios that move PTCT: 2 analyses, 2 positive, 0 negative.

1. 2026-10-15 · RARE's Fayuvi approval triggers second $203 million PRV sale — ▲ · impact +37 · confidence low · horizon weeks
2. 2026-09-30 · uniQure plunges after additional Huntington's disease study data — ▲ · impact +50 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing